Hershey Reports Mint Sales Boost from 20% of U.S. GLP-1 Drug Users
HSY•Hershey reported increased mint sales driven by breath-freshening demand from GLP-1 weight-loss drug users, noting 20% of US households were using these therapies as of December 2023. Management said GLP-1 adoption is extending into confectionery trends, boosting functional candy categories.
1. Mint Sales Driven by GLP-1 Trends
Hershey noted a marked rise in mint unit volumes and sales, attributing growth to consumers on GLP-1 weight-loss drugs who are seeking breath-freshening solutions. This uptick underscores the impact of medical weight-loss therapies on confectionery demand patterns.
2. Rising GLP-1 Adoption Boosts Functional Confectionery
Management highlighted that as of December 2023, 20% of US households were using GLP-1 therapies, and said broader adoption is lifting demand for functional candy categories like mints. The company sees this trend as an opportunity to expand its mint portfolio and capitalize on evolving consumer needs.
